Plato Investment Management Ltd Invests $1.03 Million in Astera Labs, Inc. $ALAB

Plato Investment Management Ltd purchased a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 2,141 shares of the company’s stock, valued at approximately $1,028,000.

Other large investors have also recently bought and sold shares of the company. Reflection Asset Management acquired a new stake in shares of Astera Labs in the fourth quarter worth about $25,000. Smartleaf Asset Management LLC increased its holdings in shares of Astera Labs by 422.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after acquiring an additional 152 shares during the last quarter. Towarzystwo Funduszy Inwestycyjnych PZU SA bought a new position in shares of Astera Labs in the 4th quarter valued at approximately $33,000. Whipplewood Advisors LLC raised its stake in shares of Astera Labs by 15,950.0% in the 1st quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock valued at $35,000 after acquiring an additional 319 shares in the last quarter. Finally, Assetmark Inc. lifted its holdings in Astera Labs by 78.9% in the 4th quarter. Assetmark Inc. now owns 229 shares of the company’s stock worth $38,000 after purchasing an additional 101 shares during the last quarter. 60.47% of the stock is currently owned by institutional investors.

Astera Labs Price Performance

Astera Labs stock opened at $303.44 on Wednesday. The firm has a market capitalization of $52.64 billion, a P/E ratio of 150.22 and a beta of 3.84. The stock has a fifty day moving average price of $356.72 and a two-hundred day moving average price of $242.75. Astera Labs, Inc. has a 52-week low of $97.89 and a 52-week high of $499.48.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, beating the consensus estimate of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company had revenue of $392.40 million for the quarter, compared to the consensus estimate of $360.85 million. During the same quarter in the previous year, the company earned $0.44 EPS. The firm’s revenue for the quarter was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, equities research analysts predict that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Insider Activity

In other news, Director Jack R. Lazar sold 10,000 shares of the firm’s stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $355.17, for a total transaction of $3,551,700.00. Following the completion of the sale, the director owned 75,688 shares of the company’s stock, valued at approximately $26,882,106.96. This trade represents a 11.67% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 400,000 shares of Astera Labs stock in a transaction that occurred on Thursday, May 21st. The shares were sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the completion of the transaction, the chief operating officer owned 5,064,213 shares of the company’s stock, valued at $1,470,141,033.90. This trade represents a 7.32% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 631,979 shares of company stock valued at $215,479,247. Company insiders own 10.40% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on ALAB shares. JPMorgan Chase & Co. upped their target price on Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 6th. TD Cowen dropped their target price on shares of Astera Labs from $425.00 to $375.00 and set a “hold” rating on the stock in a report on Wednesday, August 5th. Northland Securities upgraded Astera Labs from a “market perform” rating to an “outperform” rating and set a $350.00 price target for the company in a report on Monday. Bank of America increased their target price on shares of Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a research note on Tuesday, June 23rd. Finally, Roth Capital reiterated a “buy” rating and set a $450.00 price target on shares of Astera Labs in a research note on Wednesday, August 5th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and eight have given a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $333.00.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.